| __timestamp | Exelixis, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 50829000 | 31073000 |
| Thursday, January 1, 2015 | 57305000 | 43216000 |
| Friday, January 1, 2016 | 116145000 | 50679000 |
| Sunday, January 1, 2017 | 159362000 | 79171000 |
| Monday, January 1, 2018 | 206366000 | 168218000 |
| Tuesday, January 1, 2019 | 228244000 | 210796000 |
| Wednesday, January 1, 2020 | 293355000 | 203613000 |
| Friday, January 1, 2021 | 401715000 | 234273000 |
| Saturday, January 1, 2022 | 459856000 | 265784000 |
| Sunday, January 1, 2023 | 542705000 | 344501000 |
| Monday, January 1, 2024 | 492128000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Over the past decade, Exelixis, Inc. and Insmed Incorporated have shown distinct trends in their SG&A expenditures. From 2014 to 2023, Exelixis has seen a staggering 967% increase in SG&A costs, peaking in 2023. In contrast, Insmed's SG&A expenses grew by 1,008% over the same period, indicating a slightly higher growth rate. Despite Exelixis's higher absolute expenses, Insmed's rapid increase suggests aggressive expansion strategies. Investors should consider these trends when evaluating the operational efficiency and strategic direction of these companies. As the biotech sector continues to evolve, effective cost management will remain a key differentiator for success.
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Insmed Incorporated
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Exelixis, Inc.
SG&A Efficiency Analysis: Comparing GSK plc and Insmed Incorporated
Breaking Down SG&A Expenses: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Insmed Incorporated or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Insmed Incorporated or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Insmed Incorporated vs Dynavax Technologies Corporation
Who Optimizes SG&A Costs Better? Insmed Incorporated or Galapagos NV
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Alkermes plc
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and CRISPR Therapeutics AG
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Soleno Therapeutics, Inc.